Pharmarise Holdings, The Current Fiscal Year Net Income Revised Downward to a Loss

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Wed Dec 25, 2024 3:00 pm JST Earnings

2796 Pharmarise Holdings Corporation 【J-GAAP】

Earnings Report

Pharmarise Holdings Corporation <2796> [TSE Std] announced its financial results in the afternoon session on December 25th (15:00). The consolidated net income/loss for the cumulative second quarter of the fiscal year ending May 2025 (June to November) turned into a loss of 113 million yen (compared to a profit of 273 million yen in the same period last year), reversing from the forecast of a 31 million yen to a loss.

In addition, the full-year consolidated net income/loss has been revised downward from an expected profit of 40 million yen to a loss of 214 million yen (compared to a loss of 351 million yen in the previous period), turning to a loss outlook.

Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated net loss for the December to May period (2H) is expected to further decrease loss of 101 million yen (compared to a loss of 624 million yen in the same period last year).

In the most recent three-month period, from September to November (2Q), the consolidated net income significantly dropped to 18 million yen, a 88.0% decrease compared to the same period last year. The operating profit margin worsened from 2.8% in the same period last year to 0.3%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jun - Nov, 2022	25,745	573	566	72	7.8	39.6	Dec 29, 2022	J-GAAP
Jun - Nov, 2023	26,948	710	701	273	28.3	84.2	Dec 25, 2023	J-GAAP
Jun - Nov, 2024	30,544	100	29	-113	-10.1	20.3	Dec 25, 2024	J-GAAP
YoY	+13.3%	-85.9%	-95.9%	－	－

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jun - Nov, 2024 Guidance	30,539	483	428	31	2.7	0	Jun 28, 2024	J-GAAP
Jun - Nov, 2024 Results	30,544	100	29	-113	-10.1	0	Dec 25, 2024	J-GAAP
Revision Rate	+0.0%	-79.3%	-93.2%	－	－

Guidance Update

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
May, 2025 Prev	60,880	949	804	40	3.5	14	Jun 28, 2024	J-GAAP
May, 2025 New	64,734	350	143	-214	-18.8	14	Dec 25, 2024	J-GAAP
Revision Rate	+6.3%	-63.1%	-82.2%	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec - May, 2023	27,518	206	132	-624	-59.4	20	Jun 28, 2024	J-GAAP
Dec - May, 2024 Guidance	34,190	250	114	-101	-8.9	14	Dec 25, 2024	J-GAAP
YoY	+24.2%	+21.4%	-13.6%	+83.8%	+85.0%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
May, 2023	52,030	1,438	1,431	333	35.5	14	Jul 11, 2023	J-GAAP
May, 2024	54,466	916	833	-351	-33.4	20	Jun 28, 2024	J-GAAP
May, 2025 Guidance	64,734	350	143	-214	-18.8	14	Dec 25, 2024	J-GAAP
YoY	+18.9%	-61.8%	-82.8%	+39.0%	+43.6%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Sep - Nov, 2023	13,477	379	370	150	15.5	2.8	Dec 25, 2023	J-GAAP
Dec - Feb, 2023	13,726	153	98	-96	-9.3	1.1	Mar 25, 2024	J-GAAP
Mar - May, 2024	13,792	53	34	-528	-50.3	0.4	Jun 28, 2024	J-GAAP
Jun - Aug, 2024	15,231	52	23	-131	-11.7	0.3	Sep 25, 2024	J-GAAP
Sep - Nov, 2024	15,313	48	6	18	1.6	0.3	Dec 25, 2024	J-GAAP
YoY	+13.6%	-87.3%	-98.4%	-88.0%	-89.6%